This paper appears in the following:
- More ApoE4 Means More Amyloid in Brains of Middle-Aged
- St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD?
- Medical Foods—Fallback Option for Elusive AD Drug Status?
- Early ApoE4 Memory Effects, But Do You Really Want to Know?
- Miami: Age and Amyloid—What Has ApoE Got to Do With It?
- St. Louis: Imaging Preclinical AD—Can You See it Coming in the Brain?
- On Your “Virtual” Bike! Exercise and Exergames Bring Benefits
- HAI Seattle: Not Just Amyloid, Not Just PIB
- HAI Seattle: Biomarkers Closing in on AD Pathological Sequence?
- Toronto: Human Amyloid Imaging Conference Showcases a Maturing Field
- Phoenix: Trials in Colombia and the U.S. for Those at Highest Risk?
- St. Louis: ApoE—A Clearer View of its Role In AD?